Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin Microneedle Pad for Secondary Raynaud's Phenomenon in Systemic Sclerosis
NCT07759557Phase 3Not yet recruiting
- Sponsor
- Khon Kaen University
- Start
- Aug 2026
- Primary completion
- Jul 2028
01
Overview
A Phase 3 trial of botulinum toxin type A in Raynaud's phenomenon (RP), systemic sclerosis (SSc), sponsored by Khon Kaen University. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
Raynaud's phenomenon (RP)systemic sclerosis (SSc)
Beyond the preview
Go deeper on NCT07759557.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07759557.